The Masonic Cancer Center, University of Minnesota serves as the focal point for cancer research at the University. As a National Cancer Institute designated comprehensive cancer center our 500 members apply their expertise to the broad problem of cancer with research in cancer causes, prevention, treatment, outcomes, and survivorship. Read more about current research in our Research Update 2013 (pdf).
The Masonic Cancer Center supports cancer research through:
Research conducted at the Masonic Cancer Center is organization into seven program that focus on specific scientific themes: Prevention and Etiology, Carcinogenesis and Chemoprevention, Genetic Mechanisms of Cancer, Tumor Microenvironment, Immunology, Cell Signaling, and Transplant Biology and Therapy.
Translational Working Groups
The Translational Working Groups (TWGs) are a mechanism to foster interprogrammatic and translational research to promote new discoveries. TWGs organize MCC members from various research programs into groups designed to address site-specific cancers, foster collaborations, and provide the necessary scientific and clinical expertise to improve outcomes for the specific disease sites.
The Masonic Cancer Center supports researchers by providing access to technologies, services and scientific consultation that help to enhance their scientific productivity. Its designation by the National Cancer Institutes as a comprehensive cancer center provides support for shared resources that can be used by cancer center members.
Since our designation as a comprehensive cancer center in 1997, the number of funded research projects has doubled to over 400 active projects and many of these projects represent collaboration between two or more faculty members.
We've complied a list of funding sources for cancer-related research from the Masonic Cancer Center, the University of Minnesota and external sources.